Literature DB >> 29989917

Metabolic evaluation guidelines in patients with nephrolithiasis: Are they being followed? Results of a national, multi-institutional, quality-assessment study.

Sabrina S Harmouch1, Hiba Abou-Haidar1, Hassan Elhawary2, Thomas Grgic3, Andrea G Lantz4, Jason Y Lee5, Ben H Chew3, Sero Andonian2, Naeem Bhojani1.   

Abstract

INTRODUCTION: The significant cost burden of kidney stones underscores the importance of best clinical practice in kidney stone management. We evaluated adherence to kidney stone metabolic evaluation guidelines in a Canadian population and the interest of patients with regard to prevention.
METHODS: A questionnaire based on Canadian Urological Association (CUA) best practice guidelines was designed. Patients presenting for extracorporeal shockwave lithotripsy treatment (ESWL) were administered this questionnaire to evaluate risk factors of stone disease and assess the use of metabolic evaluations. Patients were asked if they received explanations about their results and if they were interested in kidney stone prevention.
RESULTS: We identified 530 patients at five academic institutions; 79.4% had at least one indication to receive a metabolic evaluation (high-risk stone formers), which increased to 96.6% if first-time stone formers whom reported an interest in metabolic evaluation were included. However, only 41.1 % of these patients had a metabolic evaluation. Endourologists ordered metabolic evaluation more often than other referring urologists (63.6% vs. 36.5%; p<0.001). Furthermore, urologists ordered metabolic evaluations more often than other prescribing physicians (68.9% vs. 31.1%; p<0.001). Sixty-two percent of patients received explanations about their metabolic evaluation results and 77.5% understood them. Regarding prevention, 84.1% and 83.8% were interested in more explanations and in following a diet or taking a medication, respectively.
CONCLUSIONS: Adherence to CUA metabolic evaluation guidelines is suboptimal and could be improved by urologists referring patients for ESWL. Communication between physician and patient may not be adequate. The majority of stone formers are interested in kidney stone prevention.

Entities:  

Year:  2018        PMID: 29989917      PMCID: PMC6192751          DOI: 10.5489/cuaj.5155

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  21 in total

1.  Urologic diseases in America project: urolithiasis.

Authors:  Margaret S Pearle; Elizabeth A Calhoun; Gary C Curhan
Journal:  J Urol       Date:  2005-03       Impact factor: 7.450

Review 2.  Economics of stone management.

Authors:  Yair Lotan; Margaret S Pearle
Journal:  Urol Clin North Am       Date:  2007-08       Impact factor: 2.241

3.  Trends in percutaneous nephrolithotomy use and outcomes in the United States.

Authors:  Khurshid R Ghani; Jesse D Sammon; Naeem Bhojani; Pierre I Karakiewicz; Maxine Sun; Shyam Sukumar; Ray Littleton; James O Peabody; Mani Menon; Quoc-Dien Trinh
Journal:  J Urol       Date:  2013-02-19       Impact factor: 7.450

4.  Recurrence after a single renal stone in a community practice.

Authors:  J W Sutherland; J H Parks; F L Coe
Journal:  Miner Electrolyte Metab       Date:  1985

5.  10-year experience with extracorporeal shockwave lithotripsy in the state of Colorado.

Authors:  S A Grampsas; M Moore; P S Chandhoke
Journal:  J Endourol       Date:  2000-11       Impact factor: 2.942

6.  The financial effects of kidney stone prevention.

Authors:  J H Parks; F L Coe
Journal:  Kidney Int       Date:  1996-11       Impact factor: 10.612

7.  Prevalence of kidney stones in the United States.

Authors:  Charles D Scales; Alexandria C Smith; Janet M Hanley; Christopher S Saigal
Journal:  Eur Urol       Date:  2012-03-31       Impact factor: 20.096

8.  Trends in surgery for upper urinary tract calculi in the USA using the Nationwide Inpatient Sample: 1999-2009.

Authors:  Khurshid R Ghani; Jesse D Sammon; Pierre I Karakiewicz; Maxine Sun; Naeem Bhojani; Shyam Sukumar; James O Peabody; Mani Menon; Quoc-Dien Trinh
Journal:  BJU Int       Date:  2013-03-11       Impact factor: 5.588

Review 9.  Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials.

Authors:  Howard A Fink; Joseph W Akornor; Pranav S Garimella; Rod MacDonald; Andrea Cutting; Indulis R Rutks; Manoj Monga; Timothy J Wilt
Journal:  Eur Urol       Date:  2009-03-13       Impact factor: 20.096

10.  Evidence for durable kidney stone prevention over several decades.

Authors:  Joan H Parks; Fredric L Coe
Journal:  BJU Int       Date:  2008-11-18       Impact factor: 5.588

View more
  2 in total

1.  The metabolic stone evaluation: An opportunity for shared decision-making.

Authors:  Darren Beiko
Journal:  Can Urol Assoc J       Date:  2018-10       Impact factor: 1.862

2.  Inappropriate use of clinical practices in Canada: a systematic review.

Authors:  Janet E Squires; Danielle Cho-Young; Laura D Aloisio; Robert Bell; Stephen Bornstein; Susan E Brien; Simon Decary; Melissa Demery Varin; Mark Dobrow; Carole A Estabrooks; Ian D Graham; Megan Greenough; Doris Grinspun; Michael Hillmer; Tanya Horsley; Jiale Hu; Alan Katz; Christina Krause; John Lavis; Wendy Levinson; Adrian Levy; Michelina Mancuso; Steve Morgan; Letitia Nadalin-Penno; Andrew Neuner; Tamara Rader; Wilmer J Santos; Gary Teare; Joshua Tepper; Amanda Vandyk; Michael Wilson; Jeremy M Grimshaw
Journal:  CMAJ       Date:  2022-02-28       Impact factor: 16.859

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.